Vitamin D treatment of peripheral blood mononuclear cells modulated immune activation and reduced susceptibility to HIV-1 infection of CD4+ T lymphocytes.

Mucosal immune activation, in the context of sexual transmission of HIV-1 infection, is crucial, as the increased presence of activated T cells enhance susceptibility to infection. In this regard, it has been proposed that immunomodulatory compounds capable of modulating immune activation, such as V...

Full description

Autores:
Gonzalez SM
Aguilar-Jimenez W
Trujillo-Gil E
Zapata Builes, Wildeman
Su RC
Ball TB
Rugeles MT
Tipo de recurso:
Article of journal
Fecha de publicación:
2023
Institución:
Universidad Cooperativa de Colombia
Repositorio:
Repositorio UCC
Idioma:
OAI Identifier:
oai:repository.ucc.edu.co:20.500.12494/50862
Acceso en línea:
https://doi.org/10.1371/journal.pone.0222878
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072621197&doi=10.1371%2fjournal.pone.0222878&partnerID=40&md5=b78f8c6531c0f729ab14e3d5dc1a8943
https://hdl.handle.net/20.500.12494/50862
Palabra clave:
ADP RIBOSYL CYCLASE/CYCLIC ADP RIBOSE HYDROLASE 1
ANTIMICROBIAL CATIONIC PEPTIDE
APOBEC3G GENE
APOBEC3G PROTEIN, HUMAN
APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G
ARTICLE
BLOOD
CALCITRIOL
CAMP GENE
CANADA
CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN
CATHELICIDIN
CD4+ T LYMPHOCYTE
CELL CLONING
CELL CULTURE
COHORT ANALYSIS
COLOMBIA
CONTROLLED STUDY
DRUG EFFECT
FEMALE
GRANZYME
HLA DR ANTIGEN
HUMAN
HUMAN CELL
HUMAN IMMUNODEFICIE
HUMAN IMMUNODEFICIENCY VIRUS INFECTION
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN
IMMUNOMODULATION
IN VITRO STUDY
INFECTION SENSITIVITY
INTERLEUKIN 2
LYMPHOCYTE ACTIVATION
LYMPHOCYTE FUNCTION
MACROPHAGE INFLAMMATORY PROTEIN 1BETA
MALE
PERIPHERAL BLOOD MONONUCLEAR CELL
PROTEIN EXPRESSION
SERODIAGNOSIS
T LYMPHOCYTE SUBPOPULATION
VIRAL TROPISM
VIRUS GENE
VIRUS RECEPTOR
VIRUS STRAIN
VITAMIN
Rights
openAccess
License
http://purl.org/coar/access_right/c_abf2
Description
Summary:Mucosal immune activation, in the context of sexual transmission of HIV-1 infection, is crucial, as the increased presence of activated T cells enhance susceptibility to infection. In this regard, it has been proposed that immunomodulatory compounds capable of modulating immune activation, such as Vitamin D (VitD) may reduce HIV-1 transmission and might be used as a safe and cost-effective strategy for prevention. Considering this, we examined the in vitro effect of the treatment of peripheral blood mononuclear cells (PBMCs) with the active form of VitD, calcitriol, on cellular activation, function and susceptibility of CD4+ T cells to HIV-1 infection.